- Home
-
Insights
-
All articles
- Genioo sponsors PEI Operating Partners Forum Europe
- Why most projects fail before they even start
- We succeed together
- Defined 20-year API production strategy for a pharmaceutical company
- Enabled a global pharmaceutical company to become an industry leader through end-to-end streamlining of its supply chain
- Set up supply chain transformation program for a large pharmaceutical company with organization-wide alignment and ownership
- Led SI&OP transformation for global specialty chemicals company to address supply chain issues
- Identified COGS reduction opportunities in top 20 molecules for a global leader in generic and biosimilars
- Supported global pharmaceutical company in integrating multiple TechOps organizations into one global division
- Led Top Team Alignment workshop to craft the three to five year strategy of a technical organization
- Productivity program to free up USD 500m to fuel future growth
- Supported a leading life sciences company in global transformation to generate 200m USD in annual savings
- Accelerated results for a PE-owned life sciences company through improved transparency and decision-making
- Managed large TechOps transformation for a global pharmaceutical company, resulting in 20% core COGS improvement
- Supported digital go-to-market model ideation and planning workshop for a leading pharmaceutical company
- Digital partnership rollout for a global pharmaceutical company to better reach HCPs through digital sales channels
- Data-driven replenishment optimization (DDRO) solution pilot that yielded a EUR 20m business case in 12 weeks
- Managed all integration activities of a digital visualization company acquired by a medical device firm
- Managed cross-functional PMI activities of an early stage device company
- Developed operating model ”playbook” for the CMO organization of a large pharmaceutical company following a large merger
- Led change management workshops for large pharmaceutical company, with high client satisfaction and measurable impact
- Designed an integrated “learning strategy” with underlying learning platform, for a global pharmaceutical company
- Helped define future organizational IT capabilities and workforce transformation program for a global pharmaceutical company
- Supported refresh of a medical device firm’s China strategy and roadmap, with focus on new growth opportunities
- Developed a corporate strategy for a biotech with a focus on accelerating investments and footprint in China
- Performed biosimilars landscape study for a leading generics company to assess risks to growth projections
- Supported large medical device organization in BD&L assessment of a potential acquisition target
- Established strategic plan to redefine the commercial and manufacturing strategy of a leading biopharma CDMO
- Increased scientific rigor, cost reduction and spend transparency for local clinical trials
- Increased compliance and empowered medical affairs through the implementation of innovative solutions
- Improved cross-functional stage gate product development process for a medical device company
- Proposed R&D reorganization of pre-clinical development functions to a more decentralized operating model
- Supported 18-month overall R&D transformation to reduce high overhead of divested project portfolio
- Managed risk and compliance remediation of multiple FDA-certified sites for production of sterilized products
- Defined a procurement roadmap for a biotech start-up with a virtual business model
- Set up global Spare Parts Management Program across 35 production sites resulting in annual savings of >USD 50m
- Set up global centers of excellence for procurement and supply chain; generated sourcing savings of USD 120m
- Helped global Car-T biotech company to commercialize their technology in partnership with leading pharmaceutical company and CMOs
- Helped define and embed global market access excellence across the organization of a large pharmaceutical company
- Set up commercial structure and launch plan for a recently approved rare disease gene therapy drug
- Managed launch program for a next-generation OTC treatment product in four markets
- Standardized and streamlined a medical device firm's annual brand planning process
- The surprising links between M&A trends and Digital focus in Pharma
- Partnering to procure value
- Genioo Expertise Expands Beyond Borders for Ambitious Clients with Big Ideas!
- With profitability under the microscope, how can life sciences fight back?
- Blog
- Whitepapers
- Case studies
- Projects
-
Project
- Defined 20-year API production strategy for a pharmaceutical company
- Enabled a global pharmaceutical company to become an industry leader through end-to-end streamlining of its supply chain
- Set up supply chain transformation program for a large pharmaceutical company with organization-wide alignment and ownership
- Led SI&OP transformation for global specialty chemicals company to address supply chain issues
- Identified COGS reduction opportunities in top 20 molecules for a global leader in generic and biosimilars
- Supported global pharmaceutical company in integrating multiple TechOps organizations into one global division
- Led Top Team Alignment workshop to craft the three to five year strategy of a technical organization
- Productivity program to free up USD 500m to fuel future growth
- Supported a leading life sciences company in global transformation to generate 200m USD in annual savings
- Accelerated results for a PE-owned life sciences company through improved transparency and decision-making
- Managed large TechOps transformation for a global pharmaceutical company, resulting in 20% core COGS improvement
- Supported digital go-to-market model ideation and planning workshop for a leading pharmaceutical company
- Digital partnership rollout for a global pharmaceutical company to better reach HCPs through digital sales channels
- Data-driven replenishment optimization (DDRO) solution pilot that yielded a EUR 20m business case in 12 weeks
- Managed all integration activities of a digital visualization company acquired by a medical device firm
- Managed cross-functional PMI activities of an early stage device company
- Developed operating model ”playbook” for the CMO organization of a large pharmaceutical company following a large merger
- Led change management workshops for large pharmaceutical company, with high client satisfaction and measurable impact
- Designed an integrated “learning strategy” with underlying learning platform, for a global pharmaceutical company
- Helped define future organizational IT capabilities and workforce transformation program for a global pharmaceutical company
- Supported refresh of a medical device firm’s China strategy and roadmap, with focus on new growth opportunities
- Developed a corporate strategy for a biotech with a focus on accelerating investments and footprint in China
- Performed biosimilars landscape study for a leading generics company to assess risks to growth projections
- Supported large medical device organization in BD&L assessment of a potential acquisition target
- Established strategic plan to redefine the commercial and manufacturing strategy of a leading biopharma CDMO
- Increased scientific rigor, cost reduction and spend transparency for local clinical trials
- Increased compliance and empowered medical affairs through the implementation of innovative solutions
- Improved cross-functional stage gate product development process for a medical device company
- Proposed R&D reorganization of pre-clinical development functions to a more decentralized operating model
- Supported 18-month overall R&D transformation to reduce high overhead of divested project portfolio
- Managed risk and compliance remediation of multiple FDA-certified sites for production of sterilized products
- Defined a procurement roadmap for a biotech start-up with a virtual business model
- Set up global Spare Parts Management Program across 35 production sites resulting in annual savings of >USD 50m
- Set up global centers of excellence for procurement and supply chain; generated sourcing savings of USD 120m
- Helped global Car-T biotech company to commercialize their technology in partnership with leading pharmaceutical company and CMOs
- Helped define and embed global market access excellence across the organization of a large pharmaceutical company
- Set up commercial structure and launch plan for a recently approved rare disease gene therapy drug
- Managed launch program for a next-generation OTC treatment product in four markets
- Standardized and streamlined a medical device firm's annual brand planning process
- Articles
- Interviews
-
All articles
- About us
- Contact
- Join us
- News & Events
- Search
- Sitemap
- Locations
- Event tracking examples
- Terms and conditions